Jordan University Hospital
Amman, Al Jubaiha, 11942, Jordan
NCT Number: NCT05483348
To determine the predictive factors of endometrial ablation failure in the management of uterine bleeding.
Looking for future studies?
Notify MeFemale
Observational
Amman, Al Jubaiha, 11942, Jordan
This is a retrospective cohort study for women who have been treated with Thermal endometrial ablation due to uterine bleeding. The main purpose of this study is to demonstrate the possible risk factors associated with endometrial ablation failure causing patients to need subsequent gynecological procedures or undergoing hysterectomy for definitive treatment. Such efforts are made in order to anticipate the morbidity and mortality associated with patients in such conditions and to effectively stratify those patients to appropriate treatment techniques.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Thermal endometrial ablation
subsequent gynecological procedures such as hysterectomy for any benign indication, D&C or repeat ablation.
Time frame: from September 2016 through February 2022
the outcome of hysteroscopic endometrial ablation whether it was a failure or a success; failure was defined as persistent of heavy bleeding after the ablation.
Time frame: from September 2016 through February 2022
To find the failure rate of endometrial ablation that is done for uterine bleeding
Time frame: from September 2016 through February 2022
To find the subsequent gynecological procedures that patients with unsuccessful ablation had
Naser Al-Husban
Other
Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection; Retrospective Study at a Tertiary University Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06219538
Cesarean Section Complications, Female Urogenital Diseases
Norfolk, Virginia, United States
View Trial DetailsNCT07046949
Acute Pain, Agnosia
Rivne, Rivne Oblast, Ukraine
View Trial DetailsNCT06707051
Abormal utèrine Bleeding, Agranulocytosis
Sahiwal, Punjab Province, Pakistan
View Trial DetailsNCT04434066
Abnormal Uterine Bleeding, Endometriosis
Dallas, Texas, United States
View Trial Details